The Gpnmb transgenic rats under the control of liver specific human serum amyloid P (SAP) promoter were protected from liver fibrosis under choline-deficient, L-amino acid-defined (CDAA) diet34. This evidence concerns the gene GPNMB and Hepatic fibrosis.